Syncaid Pharmaceuticals Private Limited
Founded in 2016 and headquartered in Uttar Pradesh, India.
2016 | Ghaziabad, Uttar Pradesh (India) | Active
Syncaid Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2016
About Syncaid Pharmaceuticals
Syncaid Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 January 2016 (Nine years and one month 9 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanchit Chauhan and Sanjay Maura serve as directors at the Company.
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74120UP2016PTC075830
- Company No.
075830
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2016
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Professional Services
Who are the key members and board of directors at Syncaid Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanchit Chauhan  | Director | 18-Jan-2016 | Current |
| Sanjay Maura | Director | 18-Jan-2016 | Current |
Financial Performance of Syncaid Pharmaceuticals.
Enhance accessibility to Syncaid Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Syncaid Pharmaceuticals?
In 2016, Syncaid Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Redhorse Footwear Private Limited
Sanchit Chauhan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Syncaid Pharmaceuticals?
Unlock and access historical data on people associated with Syncaid Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syncaid Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syncaid Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.